Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2928 |
|
Actual shortage: | 212 (7%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 10 (0%) | |
Resolved: | 2706 (92%) | |
Discontinuation Reports |
299 |
|
To be discontinued: | 2 (1%) | |
Discontinued: | 297 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
361 (11%) |
|
Overdue reports |
86 (40%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-EVEROLIMUS | 5MG | TABLET | Actual shortage | 2024-05-09 | 2025-04-10 | 227509 |
TEVA-EVEROLIMUS | 2.5MG | TABLET | Resolved | 2020-08-13 | 2020-09-03 | 122201 |
TEVA-EVEROLIMUS | 5MG | TABLET | Resolved | 2020-09-24 | 2020-10-08 | 124971 |
TEVA-EVEROLIMUS | 2.5MG | TABLET | Resolved | 2020-10-01 | 2021-01-14 | 125503 |
TEVA-EVEROLIMUS | 2.5MG | TABLET | Resolved | 2022-10-28 | 2022-12-08 | 173058 |
TEVA-EVEROLIMUS | 2.5MG | TABLET | Resolved | 2020-04-10 | 2020-05-14 | 111807 |
TEVA-EXEMESTANE | 25MG | TABLET | Resolved | 2023-02-02 | 2023-04-28 | 183416 |
TEVA-EXEMESTANE | 25MG | TABLET | Resolved | 2023-06-08 | 2023-10-04 | 194175 |
TEVA-EXEMESTANE | 25MG | TABLET | Resolved | 2023-06-19 | 2023-07-05 | 195569 |
TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2023-11-03 | 2024-01-25 | 209125 |
TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2023-11-03 | 2023-11-23 | 209130 |
TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2023-11-03 | 2024-01-25 | 209133 |
TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2020-06-04 | 2020-06-11 | 116666 |
TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2020-09-03 | 2021-01-07 | 123726 |
TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2021-02-18 | 2021-03-11 | 134331 |
TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2021-03-25 | 2021-04-01 | 136338 |
TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2021-05-13 | 2021-09-02 | 139300 |
TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2021-06-17 | 2021-07-22 | 141122 |
TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2021-06-17 | 2021-07-15 | 141128 |
TEVA-EZETIMIBE | 10MG | TABLET | Actual shortage | 2024-02-08 | 2024-02-08 | 218980 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
CLOXACILLIN SODIUM FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14018 |
CLOXACILLIN SODIUM FOR INJECTION | 2G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14021 |
DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63937 | ||
DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63940 | ||
EPIRUBICIN FOR INJECTION | 2MG | SOLUTION | Discontinued | 2020-10-22 | 2020-10-24 | 126906 |
EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106170 | ||
EPTIFIBATIDE INJECTION | 0.75MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14024 |
EPTIFIBATIDE INJECTION | 2MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14027 |
EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106176 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106155 | ||
GEMCITABINE FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14033 |
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81337 | ||
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81344 | ||
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81330 | ||
HYDROCORTISONE SODIUM SUCCINATE INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81347 | ||
LEUCOVORIN CALCIUM INJECTION | 10MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14036 |
LINEZOLID INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106173 | ||
METHOTREXATE SODIUM INJECTION | 25MG | SOLUTION | Discontinued | 2025-04-25 | 2025-04-25 | 255818 |